Pacific Biosciences of Ca...

NASDAQ: PACB · Real-Time Price · USD
1.29
0.06 (4.88%)
At close: Aug 15, 2025, 3:07 PM

Pacific Biosciences of California Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
39.77M 37.15M 39.22M 39.97M 36.01M 38.81M 58.36M 55.69M 47.57M 38.9M 27.35M 32.31M 35.47M 33.17M 36.02M 34.89M 30.61M 29M
Cost of Revenue
25.08M 400.57M 29.17M 29.96M 30.07M 27.53M 48.79M 37.79M 32.03M 29.14M 22.21M 18.76M 19.27M 19.02M 19.25M 19.52M 16.86M 16.02M
Gross Profit
14.68M -363.41M 10.06M 10M 5.94M 11.28M 9.57M 17.9M 15.55M 9.76M 5.14M 13.55M 16.19M 14.15M 16.77M 15.36M 13.75M 12.98M
Operating Income
-44.02M -402.6M -153.03M -64.08M -175.85M -81.36M -87.55M -82.49M -73.17M -91.25M -82.49M -70.34M -67.97M -78.59M -64.68M -74.48M -37.57M -33.71M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.65M n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-41.9M -426.38M 2.69M -60.73M -173.32M -78.18M -82.74M -77.58M -69.83M -88.02M -84.38M -76.97M -71.39M -81.5M -68.15M -78.28M -41M -87.44M
Net Income
-41.93M -426.07M 2.37M -60.73M -173.32M -78.18M -82.02M -66.87M -69.83M -81.15M -79.84M -83.6M -71.39M -84.41M -69.33M 16.54M -41M -87.44M
Selling & General & Admin
36.17M 40.17M 41.15M 43.75M 35.72M 42.41M 46M 43.43M 40.57M 39.82M 45M 36.8M 39.25M 39.8M 37.32M 31.61M 29.06M 26.14M
Research & Development
22.53M 29.05M 27.47M 25.52M 38.48M 43.45M 44.54M 47.51M 46.17M 48.94M 42.62M 47.09M 50.35M 52.94M 42.58M 27.51M 22.27M 20.55M
Other Expenses
n/a 366.75M 94.47M n/a 107.58M 6.78M 6.58M 9.45M 1.98M n/a n/a n/a 256K -279K 1K -133K 161K 64K
Operating Expenses
58.7M 435.98M 163.09M 69.26M 181.78M 92.64M 97.12M 100.39M 88.72M 88.76M 87.63M 83.89M 89.6M 92.74M 79.9M 59.11M 51.33M 46.69M
Interest Expense
1.74M 1.74M 2.76M 3.54M 3.54M 3.58M 3.57M 3.59M 3.55M 3.63M 3.65M 3.66M 3.68M 3.7M 3.48M 3.67M 3.59M 1.79M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
83.79M 466.09M 192.25M 104.04M 211.86M 120.17M 145.91M 138.18M 120.75M 117.9M 109.84M 102.65M 108.87M 111.76M 99.15M 78.64M 68.18M 62.71M
Income Tax Expense
35K -302K 316K n/a n/a n/a -718K -10.71M n/a -6.87M -4.54M 6.63M -330K 2.91M 1.18M -94.82M n/a -543K
Shares Outstanding (Basic)
300.16M 296.86M 283M 272.92M 272.38M 269.58M 264.86M 255M 249.4M 242.03M 226.24M 225.12M 224.5M 220.27M 217.08M 202.19M 195.24M 194.3M
Shares Outstanding (Diluted)
300.16M 296.86M 306.89M 272.92M 272.38M 269.58M 267.12M 255M 250.07M 242.03M 226.24M 225.12M 224.5M 222.29M 220.73M 215.13M 198.57M 194.79M
EPS (Basic)
-0.14 -1.44 0.01 -0.22 -0.64 -0.29 -0.31 -0.26 -0.28 -0.34 -0.35 -0.37 -0.32 -0.38 -0.32 0.08 -0.21 -0.45
EPS (Diluted)
-0.14 -1.44 0.01 -0.22 -0.64 -0.29 -0.31 -0.26 -0.28 -0.34 -0.35 -0.37 -0.32 -0.38 -0.31 0.08 -0.21 -0.45
EBITDA
-35.58M -51.86M 16.39M -41.09M -155.49M -62.59M -61.31M -68.53M -61.41M -79.87M -76.01M -68.99M -63.45M -73.61M -60.59M -71.9M -35.02M -83.25M
EBIT
-40.16M -424.64M 5.44M -57.19M -169.78M -74.6M -79.17M -73.99M -66.28M -84.39M -80.27M -73.31M -67.71M -77.95M -64.67M -74.61M -37.41M -85.65M
Depreciation & Amortization
4.58M 372.78M 10.95M 16.1M 14.29M 12.01M 17.86M 5.46M 4.86M 4.52M 4.54M 4.32M 4.27M 4.19M 4.08M 2.71M 2.39M 2.4M